U.S. federal trademark · Serial No. 99087526
Monoclonal antibodies and drug conjugates for the treatment of multiple Sclerosis, Alzheimer disease, stroke, traumatic brain injury, long COVID, postoperative cognitive decline, brain B-cell lymphoma, small vessel disease (CADACIL), adrenoleukodystrophy; biological products, namely, monoclonal antibodies for experimental purposes as part of medical treatment for multiple Sclerosis, Alzheimer disease, stroke, traumatic brain injury, long COVID, postoperative cognitive decline, brain B-cell lymphoma, small vessel disease (CADACIL), adrenoleukodystrophy
Medical probes; probes for medical imaging, namely, fluorescent and PET probes; medical devices for neuroimaging, neuro-diagnostics and neuro-monitoring
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.